Dr Weibiao Cao, MD | |
593 Eddy St, Providence, RI 02903-4923 | |
(401) 444-8450 | |
(401) 444-5088 |
Full Name | Dr Weibiao Cao |
---|---|
Gender | Male |
Speciality | Pathology |
Experience | 38 Years |
Location | 593 Eddy St, Providence, Rhode Island |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528249075 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | LP01284 (Rhode Island) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
The Miriam Hospital | Providence, RI | Hospital |
Rhode Island Hospital | Providence, RI | Hospital |
Newport Hospital | Newport, RI | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Newport Hospital | 0042111437 | 34 |
The Miriam Hospital | 6901796408 | 186 |
Rhode Island Hospital | 8921900044 | 303 |
News Archive
Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease (COPD) are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions - excess mucus production.
Our brains are obsessed with being social even when we are not in social situations. A Dartmouth-led study finds that the brain may tune towards social learning even when it is at rest.
A new programme to strengthen the UK's position as a leader in the methods that underpin health research has been announced by the Medical Research Council and the National Institute for Health Research.
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the first of two pivotal Phase III LibiGel safety and efficacy trials has been completed.
BIOTRONIK SE & Co. KG, today announced the European launch of the Reliaty pacing system analyzer after CE approval and successful pre-market evaluation. The pacing system analyzer is used during an implantation of implantable pacemakers, implantable cardioverter-defibrillators and Cardiac Resynchronization Therapy systems to ensure adequate lead placement, maintenance of basic cardiac functions, and to evaluate pacing parameters for customized device programming.
› Verified 3 days ago
Entity Name | Newport Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1063632180 PECOS PAC ID: 0042111437 Enrollment ID: O20040422000696 |
News Archive
Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease (COPD) are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions - excess mucus production.
Our brains are obsessed with being social even when we are not in social situations. A Dartmouth-led study finds that the brain may tune towards social learning even when it is at rest.
A new programme to strengthen the UK's position as a leader in the methods that underpin health research has been announced by the Medical Research Council and the National Institute for Health Research.
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the first of two pivotal Phase III LibiGel safety and efficacy trials has been completed.
BIOTRONIK SE & Co. KG, today announced the European launch of the Reliaty pacing system analyzer after CE approval and successful pre-market evaluation. The pacing system analyzer is used during an implantation of implantable pacemakers, implantable cardioverter-defibrillators and Cardiac Resynchronization Therapy systems to ensure adequate lead placement, maintenance of basic cardiac functions, and to evaluate pacing parameters for customized device programming.
› Verified 3 days ago
Entity Name | Rhode Island Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1154537520 PECOS PAC ID: 8921900044 Enrollment ID: O20141017000105 |
News Archive
Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease (COPD) are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions - excess mucus production.
Our brains are obsessed with being social even when we are not in social situations. A Dartmouth-led study finds that the brain may tune towards social learning even when it is at rest.
A new programme to strengthen the UK's position as a leader in the methods that underpin health research has been announced by the Medical Research Council and the National Institute for Health Research.
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the first of two pivotal Phase III LibiGel safety and efficacy trials has been completed.
BIOTRONIK SE & Co. KG, today announced the European launch of the Reliaty pacing system analyzer after CE approval and successful pre-market evaluation. The pacing system analyzer is used during an implantation of implantable pacemakers, implantable cardioverter-defibrillators and Cardiac Resynchronization Therapy systems to ensure adequate lead placement, maintenance of basic cardiac functions, and to evaluate pacing parameters for customized device programming.
› Verified 3 days ago
Entity Name | The Miriam Hospital |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1598978744 PECOS PAC ID: 6901796408 Enrollment ID: O20170303000645 |
News Archive
Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease (COPD) are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions - excess mucus production.
Our brains are obsessed with being social even when we are not in social situations. A Dartmouth-led study finds that the brain may tune towards social learning even when it is at rest.
A new programme to strengthen the UK's position as a leader in the methods that underpin health research has been announced by the Medical Research Council and the National Institute for Health Research.
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the first of two pivotal Phase III LibiGel safety and efficacy trials has been completed.
BIOTRONIK SE & Co. KG, today announced the European launch of the Reliaty pacing system analyzer after CE approval and successful pre-market evaluation. The pacing system analyzer is used during an implantation of implantable pacemakers, implantable cardioverter-defibrillators and Cardiac Resynchronization Therapy systems to ensure adequate lead placement, maintenance of basic cardiac functions, and to evaluate pacing parameters for customized device programming.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Weibiao Cao, MD 593 Eddy St, Providence, RI 02903-4923 Ph: (401) 444-8450 | Dr Weibiao Cao, MD 593 Eddy St, Providence, RI 02903-4923 Ph: (401) 444-8450 |
News Archive
Respiratory conditions that restrict breathing such as asthma and chronic obstructive pulmonary disease (COPD) are common killers worldwide. But no effective treatments exist to address the major cause of death in these conditions - excess mucus production.
Our brains are obsessed with being social even when we are not in social situations. A Dartmouth-led study finds that the brain may tune towards social learning even when it is at rest.
A new programme to strengthen the UK's position as a leader in the methods that underpin health research has been announced by the Medical Research Council and the National Institute for Health Research.
BioSante Pharmaceuticals, Inc. today announced that enrollment of subjects in the first of two pivotal Phase III LibiGel safety and efficacy trials has been completed.
BIOTRONIK SE & Co. KG, today announced the European launch of the Reliaty pacing system analyzer after CE approval and successful pre-market evaluation. The pacing system analyzer is used during an implantation of implantable pacemakers, implantable cardioverter-defibrillators and Cardiac Resynchronization Therapy systems to ensure adequate lead placement, maintenance of basic cardiac functions, and to evaluate pacing parameters for customized device programming.
› Verified 3 days ago
Dr. Ga Hie Nam, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-5057 Fax: 401-444-8514 | |
N Peter Libbey, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 825 Chalkstone Ave, Roger Williams Medical Center/pathology Dept., Providence, RI 02908 Phone: 401-456-2162 Fax: 401-456-2131 | |
Sara Maleki, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Apc 12, Providence, RI 02903 Phone: 401-444-8515 Fax: 401-444-8514 | |
Mirfrida Geller, M.D. Pathology Medicare: Not Enrolled in Medicare Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-8450 Fax: 401-444-5088 | |
Dr. Lisa Goldstein, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 164 Summit Ave, Department Of Pathology, Providence, RI 02906 Phone: 401-793-4246 Fax: 401-274-5154 | |
Dr. Gladys Telang, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Apc 10, Providence, RI 02903 Phone: 401-444-7959 Fax: 401-444-7144 | |
Xin He, M.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 593 Eddy St, Providence, RI 02903 Phone: 401-444-4923 |